Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › NORWICH › CHENANGO MEMORIAL HOSPITAL INC

CHENANGO MEMORIAL HOSPITAL INC

NPI: 1770593956 · NORWICH, NY 13815 · General Acute Care Hospital · NPI assigned 08/09/2006

$30.65M
Total Medicaid Paid
433,815
Total Claims
398,072
Beneficiaries
262
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLAMEN, DRAKE (PRESIDENT & CEO)
NPI Enumeration Date08/09/2006

Related Entities

Other providers sharing the same authorized official: LAMEN, DRAKE

ProviderCityStateTotal Paid
CHENANGO MEMORIAL HOSPITAL, INC. NORWICH NY $6.33M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,111 $40K
2019 23,361 $1.21M
2020 66,898 $3.40M
2021 79,875 $4.57M
2022 88,535 $9.21M
2023 94,107 $7.25M
2024 78,928 $4.97M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 43,860 39,649 $6.16M
99283 Emergency department visit for the evaluation and management, moderate severity 13,382 12,714 $3.12M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 21,590 19,533 $3.06M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7,038 6,816 $1.50M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11,715 3,349 $1.21M
96361 Intravenous infusion, hydration; each additional hour 3,231 2,932 $1.18M
99284 Emergency department visit for the evaluation and management, high severity 5,628 5,386 $1.01M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4,918 4,882 $776K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 5,202 4,823 $733K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,863 4,858 $677K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,814 3,653 $666K
80053 Comprehensive metabolic panel 19,814 18,348 $653K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2,980 2,900 $645K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,292 1,266 $600K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,239 1,213 $519K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3,701 3,701 $519K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 6,053 5,872 $497K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 6,177 5,378 $473K
70450 Computed tomography, head or brain; without contrast material 1,154 1,131 $437K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,544 1,328 $315K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,080 2,059 $315K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,961 1,898 $278K
74176 Computed tomography, abdomen and pelvis; without contrast material 679 668 $276K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,922 1,916 $267K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,703 4,281 $246K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 482 481 $217K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,661 1,649 $217K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,200 4,074 $199K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 1,450 1,438 $196K
80061 Lipid panel 6,579 6,549 $181K
97161 1,239 1,219 $148K
81025 3,738 3,536 $145K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 732 728 $127K
77067 Screening mammography, bilateral, including computer-aided detection 1,365 1,365 $113K
20610 284 269 $102K
86900 1,479 1,424 $95K
90686 3,485 3,480 $93K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,670 2,660 $90K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,055 2,035 $81K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3,479 3,231 $81K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 861 808 $80K
71046 Radiologic examination, chest; 2 views 2,791 2,749 $72K
84443 Thyroid stimulating hormone (TSH) 7,729 7,612 $71K
90648 3,295 3,292 $66K
90715 2,025 2,025 $62K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 19,220 17,265 $59K
90723 2,629 2,627 $57K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 498 495 $57K
90670 2,495 2,493 $52K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 371 367 $50K
90680 2,449 2,447 $49K
83655 2,697 2,669 $48K
36415 Collection of venous blood by venipuncture 9,819 8,618 $48K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1,944 806 $48K
96110 Developmental screening, with scoring and documentation, per standardized instrument 376 376 $48K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 567 504 $47K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 296 296 $44K
86850 1,464 1,403 $43K
90633 1,939 1,939 $42K
80048 Basic metabolic panel (calcium, ionized) 1,505 1,408 $39K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1,150 1,147 $39K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,327 1,048 $38K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,055 2,035 $37K
76705 Ultrasound, abdominal, real time with image documentation; limited 461 457 $37K
72100 1,224 1,177 $34K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 526 523 $32K
81003 16,016 12,600 $31K
86703 1,757 1,750 $30K
83036 Hemoglobin; glycosylated (A1C) 5,068 5,037 $29K
90734 894 893 $28K
76830 Ultrasound, transvaginal 288 286 $27K
73630 1,142 1,092 $27K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 211 199 $26K
J1050 Injection, medroxyprogesterone acetate, 1 mg 596 596 $26K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 250 249 $25K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 559 474 $25K
99215 Prolong outpt/office vis 191 184 $25K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 127 100 $24K
90710 801 801 $22K
86901 1,507 1,443 $21K
87631 322 322 $21K
90716 814 814 $20K
77063 Screening digital breast tomosynthesis, bilateral 993 993 $20K
90651 548 547 $19K
90707 799 799 $18K
D1110 Prophylaxis - adult 316 316 $18K
87634 290 289 $18K
90700 769 769 $17K
90677 616 616 $17K
95117 307 183 $16K
96127 3,066 2,897 $15K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3,202 3,001 $15K
87486 355 350 $15K
90696 694 694 $14K
73030 832 816 $14K
73610 902 851 $14K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 6,234 5,856 $14K
59025 Fetal non-stress test 80 50 $14K
83880 366 329 $14K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 403 397 $14K
73130 910 851 $13K
82607 1,407 1,400 $13K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 115 105 $13K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 50 50 $13K
85027 3,507 3,451 $12K
90671 508 508 $12K
84439 2,142 2,113 $12K
84702 1,955 1,607 $12K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2,516 2,487 $11K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 221 191 $11K
D0120 Periodic oral evaluation - established patient 374 374 $11K
80306 2,901 2,764 $9K
85610 2,577 2,216 $9K
90656 378 378 $9K
73564 414 412 $8K
86803 1,513 1,500 $8K
87581 355 350 $8K
76801 75 73 $8K
99381 51 51 $8K
12001 13 13 $7K
93242 78 78 $7K
29125 28 28 $7K
76536 78 78 $7K
87086 Culture, bacterial; quantitative colony count, urine 5,392 5,067 $7K
73110 449 412 $6K
83735 3,306 3,010 $6K
82570 1,578 1,553 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 25 25 $6K
82043 1,403 1,391 $6K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 277 257 $6K
86618 784 778 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination 73 72 $6K
36416 336 304 $5K
80050 General health panel 36 35 $5K
72040 265 256 $5K
0012A 161 161 $5K
86140 1,818 1,655 $5K
96375 Therapeutic injection; each additional sequential IV push 2,139 1,941 $4K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 30 30 $4K
86592 1,222 1,219 $4K
0011A 170 170 $4K
D1120 Prophylaxis - child 97 97 $4K
76641 49 49 $4K
87340 1,056 1,048 $4K
99441 95 94 $4K
76770 28 28 $4K
99442 72 71 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 389 384 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete 25 25 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 396 378 $3K
86039 433 430 $3K
82728 285 283 $3K
71045 Radiologic examination, chest; single view 2,500 2,413 $3K
84153 209 209 $3K
83550 446 442 $3K
G0378 Hospital observation service, per hour 183 136 $3K
94060 12 12 $2K
83540 541 537 $2K
87081 804 758 $2K
72141 12 12 $2K
87400 1,952 1,932 $2K
11721 170 164 $2K
87070 1,546 1,528 $2K
86762 560 555 $2K
93017 13 13 $2K
92552 33 33 $2K
73502 113 110 $2K
86787 638 632 $2K
85652 1,357 1,300 $2K
74018 92 89 $2K
71250 12 12 $2K
90682 87 87 $2K
84436 284 283 $2K
D0274 Bitewings - four radiographic images 55 55 $2K
96367 14 13 $2K
73562 121 120 $2K
87077 1,370 1,295 $1K
87186 1,351 1,256 $1K
83970 37 37 $1K
0064A 35 35 $1K
85730 1,330 1,287 $1K
85014 297 290 $1K
82950 209 207 $1K
82150 1,442 1,392 $1K
83690 2,040 1,948 $1K
0001A 25 25 $990.11
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 407 400 $971.72
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 28 12 $910.20
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 38 13 $814.58
83721 134 132 $807.03
93971 13 13 $787.94
85379 1,070 1,040 $749.02
84484 2,448 2,189 $716.46
85651 352 340 $664.76
84480 68 68 $657.53
80076 44 42 $567.55
82803 29 26 $541.62
87205 979 962 $522.50
86617 49 25 $469.55
87420 428 422 $459.66
85018 297 290 $422.24
0225U 48 47 $416.78
82550 403 365 $401.99
72070 12 12 $341.46
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,395 1,363 $340.21
84703 406 403 $316.43
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 357 282 $286.09
73560 25 25 $249.54
80069 26 25 $243.64
G0008 Administration of influenza virus vaccine 12 12 $242.70
84156 73 71 $221.84
86666 32 32 $217.93
90647 12 12 $215.28
90744 12 12 $214.20
82784 28 26 $204.60
86376 14 14 $189.15
86431 78 78 $186.02
86706 24 24 $170.73
D0220 Intraoral - periapical first radiographic image 13 13 $168.00
86753 22 19 $151.21
Q3014 Telehealth originating site facility fee 23 15 $128.31
87147 166 153 $114.52
73590 12 12 $78.39
82962 837 633 $77.60
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 13 13 $75.68
82948 137 95 $55.81
86308 25 25 $51.54
86430 14 14 $48.10
87040 201 164 $39.52
J7030 Infusion, normal saline solution , 1000 cc 2,470 2,229 $38.83
84550 14 13 $31.78
83605 275 250 $21.15
J7120 Ringers lactate infusion, up to 1000 cc 2,217 2,016 $16.24
J1885 Injection, ketorolac tromethamine, per 15 mg 3,889 3,595 $13.64
C9113 Injection, pantoprazole sodium, per vial 85 80 $11.37
J2704 Injection, propofol, 10 mg 1,242 1,223 $7.08
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,817 2,647 $5.71
91322 15 15 $4.70
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 96 81 $4.04
90480 13 13 $2.73
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,977 1,911 $1.82
J1200 Injection, diphenhydramine hcl, up to 50 mg 114 105 $1.06
J2765 Injection, metoclopramide hcl, up to 10 mg 15 13 $0.73
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 85 82 $0.53
J0696 Injection, ceftriaxone sodium, per 250 mg 251 215 $0.50
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 75 75 $0.36
J3010 Injection, fentanyl citrate, 0.1 mg 1,690 1,605 $0.16
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 37 27 $0.14
J0690 Injection, cefazolin sodium, 500 mg 248 226 $0.12
J2250 Injection, midazolam hydrochloride, per 1 mg 1,304 1,289 $0.06
90460 Immunization administration through 18 years of age via any route, first or only component 75 75 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 12 12 $0.00
A4649 Surgical supply; miscellaneous 87 72 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 465 438 $0.00
J7050 Infusion, normal saline solution, 250 cc 239 176 $0.00
96376 50 39 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 94 87 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 75 69 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 27 25 $0.00
94760 15 15 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 18 18 $0.00
J1170 Injection, hydromorphone, up to 4 mg 14 14 $0.00